Breedlove Robert Charles 4

What Happened Robert Charles Breedlove, Principal Accounting Officer at Phathom Pharmaceuticals (PHAT), surrendered 776 shares (treated as disposed) at an implied price of $13.61 per share for a total of $10,561. This was a tax-withholding transaction tied to restricted stock units (RSUs) rather than an open‑market sale.

Key Details

• Transaction date: 2026-01-21; Filing date: 2026-01-23 (reported on Form 4).
• Price: $13.61 per share; Total value surrendered: $10,561.
• Shares disposed: 776 (surrendered to issuer to satisfy tax withholding).
• Shares owned after transaction: Not specified in this filing.
• Footnote: F1 — These shares represent RSUs surrendered by the reporting person to the issuer to satisfy the issuer's tax withholding obligation.
• Transaction code: F (tax withholding), not a market sale or purchase. Filing appears timely.

Context This was a routine tax-withholding event tied to RSU vesting—Phathom retained the surrendered shares to cover the tax obligation. Such internal withholdings are common and do not necessarily indicate insider sentiment about the company; they differ from open-market sales where the insider receives cash.